Natalizumab De-escalation With Interferon Beta-1b

NCT01144052 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER_GOV

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: interferon beta-1b
DRUG: Natalizumab

Sponsor

Claudio Gobbi

Collaborators

[object Object]